Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/23 → 10/4/24 |
Funding
- Johnson and Johnson Consumer, Inc: $14,421.00
Activity of Johnson & Johnson Oral Formulations against HCoV-OC43
- Endsley, Mark (PI)
Project: Research project
Project: Research project
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/23 → 10/4/24 |